Groups seek insurance for immunotherapy for lung cancer patients

Focus Taiwan
Date: 2018/10/09
By: Chen Wei-ting and Elizabeth Hsu

Taipei, Oct. 9 (CNA) Two cancer-related societies in Taiwan are urging the government to

Image taken from Pixabay

allow national health insurance to cover payment for immunotherapy for late-stage lung cancer patients without having such patients receive traditional chemotherapy first.

Immunotherapy, a type of cancer treatment that boosts the body’s natural defenses to fight cancer, offers “a slim chance of survival” to late-stage lung cancer patients, said Taiwan Clinical Oncology Society President Kao Shang-jyh (高尚志) at a recent press conference in Taipei.

He pointed out that each year, more than 13,000 people in Taiwan are diagnosed with lung cancer.

Because lung cancer cannot be easily diagnosed in the early stage, but spreads quickly, over 70 percent of patients are already late stage when diagnosed, Kao said, noting that such cases can no longer be treated with surgery.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.